Powered by LatticeGrid

Search Enter term and hit return. Use '*' for as a wildcard.

Publication Listing for the MeSH term dose-escalation. Found 15 abstracts

Fury MG, Sherman E, Lisa D, Agarwal N, Algazy K, Brockstein B, Langer C, Lim D, Mehra R, Rajan SK, Korte S, Lipson B, Yunus F, Tanvetyanon T, Smith-Marrone S, Ng K, Xiao H, Hague S, Pfister DG. A Randomized Phase II Study of Cetuximab Every 2 Weeks at Either 500 or 750 mg/m(2) for Patients With Recurrent or Metastatic Head and Neck Squamous Cell Cancer. Journal of the National Comprehensive Cancer Network. 2012 Nov;10(11):1391-8.   PMCID: no NIH
Chen LL, Mu ZM, Hachem P, Ma CM, Wallentine A, Pollack A. MR-guided focused ultrasound: enhancement of intratumoral uptake of H-3 -docetaxel in vivo. Physics in Medicine and Biology. 2010 Dec;55(24):7399-410.   PMCID: not NIH funded
Robinson MK, Alpaugh RK, Borghaei H. Naptumomab estafenatox: a new immunoconjugate. Expert Opinion on Biological Therapy. 2010 Feb;10(2):273-9.   PMCID: not NIH funded
Spratlin JL, Cohen RB, Eadens M, Gore L, Camidge DR, Diab S, Leong S, O'Bryant C, Chow LQ, Serkova NJ, Meropol NJ, Lewis NL, Chiorean EG, Fox F, Youssoufian H, Rowinsky EK, Eckhardt SG. Phase I Pharmacologic and Biologic Study of Ramucirumab (IMC-1121B), a Fully Human Immunoglobulin G(1) Monoclonal Antibody Targeting the Vascular Endothelial Growth Factor Receptor-2. Journal of Clinical Oncology. 2010 Feb;28(5):780-7.   PMCID: PMC2834394
Chen Z, Ma CM, Paskalev K, Li J, Yang J, Richardson T, Palacio L, Xu X, Chen L. Investigation of MR image distortion for radiotherapy treatment planning of prostate cancer. PHYSICS IN MEDICINE AND BIOLOGY. 2006 Mar;51(6):1393-403.
Price RA, Hannoun-Levi JM, Horvvitz E, Buyyounouski M, Ruth KJ, Ma CM, Pollack A. Impact of pelvic nodal irradiation with intensity-modulated radiotherapy on treatment of prostate cancer. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS. 2006 Oct;66(2):583-92.
Chen L, Price RA, Nguyen TB, Wang L, Li JS, Qin L, Ding M, Palacio E, Ma CM, Pollack A. Dosimetric evaluation of MRI-based treatment planning for prostate cancer. Physics in Medicine and Biology. 2004 Nov 21;49(22):5157-70.
Fiveash JB, Hanks G, Roach M, Wang SB, Vigneault E, McLaughlin PW, Sandler HM. 3D conformal radiation therapy (3DCRT) for high grade prostate cancer: A multi-institutional review. International Journal of Radiation Oncology Biology Physics. 2000 May;47(2):335-42.
Lattanzi J, McNeeley S, Hanlon A, Schultheiss TE, Hanks GE. Ultrasound-based stereotactic guidance of precision conformal external beam radiation therapy in clinically localized prostate cancer. Urology. 2000 Jan;55(1):73-8.
Michalski JM, Purdy JA, Winter K, Roach M, Vijayakumar S, Sandler HM, Markoe AM, Ritter MA, Russell KJ, Sailer S, Harms WB, Perez CA, Wilder RB, Hanks GE, Cox JD. Preliminary report of toxicity following 3D radiation therapy for prostate cancer on 3DOG/RTOG 9406. International Journal of Radiation Oncology Biology Physics. 2000 Jan 15;46(2):391-402.
Hanks GE. Progress in 3D conformal radiation treatment of prostate cancer. Acta Oncologica. 1999 Jan;38:69-74.
Herold DM, Hanlon AL, Hanks GE. Diabetes mellitus: A predictor for late radiation morbidity. International Journal of Radiation Oncology Biology Physics. 1999 Feb;43(3):475-9.
Lattanzi J, McNeeley S, Pinover W, Horwitz E, Das I, Schultheiss TE, Hanks GE. A comparison of daily CT localization to a daily ultrasound- based system in prostate cancer. International Journal of Radiation Oncology Biology Physics. 1999 Mar;43(4):719-25.
Horwitz EM, Hanlon AL, Pinover WH, Hanks GE. The treatment of nonpalpable PSA-detected adenocarcinoma of the prostate with 3-dimensional conformal radiation therapy. International Journal of Radiation Oncology Biology Physics. 1998 Jun;41(3):519-23.
Lattanzi J, McNeely S, Hanlon A, Das I, Schultheiss TE, Hanks GE. Daily CT localization for correcting portal errors in the treatment of prostate cancer. International Journal of Radiation Oncology Biology Physics. 1998 Jul 15;41(5):1079-86.
The above publications are sorted by year, faculty last name, and first author. Click on any highlighted author listed to find all publications attributed to that individual. Click on the publication title to see the abstract. First authors who are faculty are highlighted like this. Last authors who are faculty are highlighted like this. Other authors who are faculty are highlighted like this.

MeSH cloud from publications including the MeSH term dose-escalation

dose-escalation radiotherapy morbidity carcinoma prostate cancer rectum complications irradiation radiation therapy optimization therapy toxicity adenocarcinoma movement motion Nuclear Medicine & Medical Imaging Radiology conformal radiation-therapy markers organ motion bladder trial radiation ct 3D conformal radiation therapy mAbs dose control target volume whole pelvic radiotherapy radiation treatment three-dimensional conformal therapy prostate-specific antigen chemotherapy prostate neoplasms reduction prostate specific antigen renal cell carcinoma oncology group liver-tumors SEA progression antitumor-activity Biomedical Engineering overdose control growth-factor receptor tumor-therapy raf kinase patient 7 days therapy simulation ultrasound rfb4(dsfv)-pe38 radical prostatectomy pancreatic cancer prognosis irinotecan brain-tumors iii randomized-trial renal-cell multicenter naptumomab immunotoxin intensity-modulated radiotherapy cancer plus cetuximab quality assurance 5t4 oncofetal antigen diabetes colorectal-cancer immobilization brain biochemical control androgen deprivation escalation tumor-control renal-cell carcinoma local- malignant-tumors biweekly cetuximab refractory solid tumors small-bowel computed tomography 3DCRT Oncology conformal radiotherapy pelvic lymphatics model T cell metastatic goserelin geometric distortion superantigen fusion proteins surgery prostate-cancer cells targeted therapy liver metastases phase-i radiation-therapy NSCLC cytokines prostate-cancer monoclonal-antibody segment superantigen tyrosine kinase drug-delivery system i clinical-trials prediction stage tie platinum-based days on advanced colorectal-cancer meningiomas
Last updated on Sunday, July 12, 2020